RIG-I promotes immune evasion of colon cancer by modulating PD-L1 ubiquitination

Colon cancer is one of the most prevalent cancers and exhibits high mortality worldwide. Despite the certain success in the immunotherapy of many tumor types, the limited response of colon cancer to immunotherapy remains a difficult problem. Retinoic acid-inducible gene-I (RIG-I) is a crucial compon...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yangyang, Zeng, Lingxiu, Wang, Meng, Yang, Zhenwei, Zhang, Hailin, Gao, Liping, Zhang, Ranran, Liu, Jialong, Shan, Wenqing, Chang, Ying, Liu, Lan, Zhao, Qiu, Li, Yong, Liu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537859/
https://www.ncbi.nlm.nih.gov/pubmed/37758653
http://dx.doi.org/10.1136/jitc-2023-007313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537859/
https://www.ncbi.nlm.nih.gov/pubmed/37758653
http://dx.doi.org/10.1136/jitc-2023-007313

Ejemplares similares